February 1, 2010

Clinical Trials: Phase II Trial of Pentostatin, Cyclophosphamide, and Ofatumumab For Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)

Sponsor and Collaborators

Mayo Clinic

Contact

Continue Reading

None listed

Principal Investigator

Tait Shanafelt, Mayo Clinic

ClinicalTrials.gov Identifier

NCT01024010

Next post in Leukemia Clinical Trials

Cinical Trials: Pilot Study of Redirected Autologous Tcells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patient With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma